The news. The narrative. The timeline.
Bureau: Chicago
Seventeen trials, 20,342 patients, no clinically meaningful benefit and a brain-bleed signal — the same week Health Canada cleared Lilly's Kisunla for early Alzheimer's.
Novo's Wegovy pill hits 113,000 weekly prescriptions in four months while Lilly's Foundayo rolls out modestly in its first, ahead of Novo's Wednesday Q1 print and TrumpRx live.
The Senate's $8.75 billion FY26 NSF mark and Trump's late-April board disbandment now run in opposite directions while the Whitehouse ADA letter sits unanswered.
Pineland Road Fire holds at 32,575 acres and 44 percent containment on Day 16 — fire behavior remains 'resistant to control' against a 40,000-acre threshold.
Utah confirms 625 measles cases — 428 from 2026, 197 from 2025 — inside a national 1,814-case total as PAHO's November elimination-status review keeps running.
Idaho's dairy outbreak still has no named vector and USDA has now formally dropped pre-movement H5N1 testing for cattle leaving unaffected states.
A peer-reviewed Science study now measures what the medical societies have been saying — the CDC's revised autism page is depressing vaccinations and confidence in the agency itself.
Three thousand radiologists head into the meeting's last full day in Washington with helium prices doubled, the federal reserve sold, and no policy answer in the room.